{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:27:57Z","timestamp":1771072077821,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jbc.2025.110341","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:06:20Z","timestamp":1749035180000},"page":"110341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interactome of FMRP-N-tat therapeutic unveils key interactions for cellular function in Fragile X neurons"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-4157","authenticated-orcid":false,"given":"K\u00e9vin","family":"Leguay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0464-6880","authenticated-orcid":false,"given":"Eva","family":"Colic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0762-6924","authenticated-orcid":false,"given":"Preya U.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4791-0530","authenticated-orcid":false,"given":"Saeideh","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen LB.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daneck","family":"Lang-Ouellette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray W.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-444X","authenticated-orcid":false,"given":"Joseph","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-4383","authenticated-orcid":false,"given":"Oliver A.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110341_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2025.110341_bib2","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/s41467-023-38039-x","article-title":"Engineering protein-based therapeutics through structural and chemical design","volume":"14","author":"Ebrahimi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110341_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.754485","article-title":"The use of peptides in the treatment of fragile X syndrome: challenges and opportunities","volume":"12","author":"Romagnoli","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jbc.2025.110341_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","article-title":"Novel targeted therapies for Parkinson\u2019s disease","volume":"27","author":"Ntetsika","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2025.110341_bib5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta. Pharm. Sin B."},{"key":"10.1016\/j.jbc.2025.110341_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1874467213666200422090135","article-title":"Recent updates in the Alzheimer\u2019s disease etiopathology and possible treatment approaches: a narrative review of current clinical trials","volume":"13","author":"Zarini-Gakiye","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110341_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110341_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jbc.2025.110341_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/GIM.0b013e31815efdd7","article-title":"Genetics evaluation for the etiologic diagnosis of autism spectrum disorders","volume":"10","author":"Schaefer","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.jbc.2025.110341_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","article-title":"Absence of expression of the FMR-1 gene in fragile X syndrome","volume":"66","author":"Pieretti","year":"1991","journal-title":"Cell."},{"key":"10.1016\/j.jbc.2025.110341_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell."},{"key":"10.1016\/j.jbc.2025.110341_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(01)00566-9","article-title":"Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function","volume":"107","author":"Darnell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110341_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13041-020-00706-1","article-title":"Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras\/MAPK, Wnt\/\u03b2-catenin, and mTOR signaling during corticogenesis","volume":"13","author":"Casingal","year":"2020","journal-title":"Mol. Brain."},{"key":"10.1016\/j.jbc.2025.110341_bib14","doi-asserted-by":"crossref","first-page":"E11397","DOI":"10.1073\/pnas.1809588115","article-title":"Regulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110341_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110341_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1101\/gr.251405.119","article-title":"Identification of FMR1-regulated molecular networks in human neurodevelopment","volume":"30","author":"Li","year":"2020","journal-title":"Genome. Res."},{"key":"10.1016\/j.jbc.2025.110341_bib17","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1038\/ncomms7634","article-title":"The amino-terminal structure of human fragile X mental retardation protein obtained using precipitant-immobilized imprinted polymers","volume":"6","author":"Hu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110341_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7692601","article-title":"FMR1 protein: conserved RNP family domains and selective RNA binding","volume":"262","author":"Ashley","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110341_bib19","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41380-019-0629-4","article-title":"Post-translational modifications of the fragile X mental retardation protein in neuronal function and dysfunction","volume":"25","author":"Prieto","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jbc.2025.110341_bib20","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1021\/bi034909g","article-title":"The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding","volume":"42","author":"Adinolfi","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110341_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/hmg\/5.8.1083","article-title":"The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals","volume":"5","author":"Eberhart","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2025.110341_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.aax4240","article-title":"Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation","volume":"365","author":"Kim","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110341_bib23","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.1814385116","article-title":"Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation","volume":"116","author":"Tsang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110341_bib24","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.bbamem.2007.06.003","article-title":"Cell-permeable peptides induce dose- and length-dependent cytotoxic effects","volume":"1768","author":"Cardozo","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.jbc.2025.110341_bib25","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Viv\u00e8s","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110341_bib26","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1038\/s41467-020-16250-4","article-title":"FMRP(1-297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome","volume":"11","author":"Zhan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110341_bib27","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0136-24.2024","article-title":"Calcium-dependent regulation of neuronal excitability is rescued in fragile X syndrome by a tat-conjugated N-terminal fragment of FMRP","volume":"44","author":"Zhan","year":"2024","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110341_bib28","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.jbc.2025.110341_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2025.110341_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07509","article-title":"Alternative isoform regulation in human tissue transcriptomes","volume":"456","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110341_bib31","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110341_bib32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.01-0995fje","article-title":"Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells","volume":"16","author":"Shaw","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2025.110341_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","article-title":"The molecular biology of FMRP: new insights into fragile X syndrome","volume":"22","author":"Richter","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jbc.2025.110341_bib34","doi-asserted-by":"crossref","first-page":"30400","DOI":"10.1073\/pnas.2009161117","article-title":"FMRP links optimal codons to mRNA stability in neurons","volume":"117","author":"Shu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110341_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110341_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyac094","article-title":"FMRP-dependent production of large dosage-sensitive proteins is highly conserved","volume":"221","author":"Flanagan","year":"2022","journal-title":"Genetics"},{"key":"10.1016\/j.jbc.2025.110341_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/febs.15443","article-title":"Novel FMRP interaction networks linked to cellular stress","volume":"288","author":"Taha","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2025.110341_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.954087","article-title":"Combining affinity purification and mass spectrometry to define the network of the nuclear proteins interacting with the N-terminal region of FMRP","volume":"9","author":"Kieffer","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"Pt 3","key":"10.1016\/j.jbc.2025.110341_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/bj3430517","article-title":"Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P","volume":"343","author":"Tamanini","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110341_bib40","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1073\/pnas.151231598","article-title":"A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P","volume":"98","author":"Schenck","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110341_bib41","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1002\/j.1460-2075.1995.tb00220.x","article-title":"The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2","volume":"14","author":"Zhang","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.110341_bib42","article-title":"DSP-Crosslinking and immunoprecipitation to isolate weak protein complex","volume":"12","author":"Akaki","year":"2022","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.jbc.2025.110341_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nmeth.1541","article-title":"SAINT: probabilistic scoring of affinity purification-mass spectrometry data","volume":"8","author":"Choi","year":"2011","journal-title":"Nat. Methods."},{"key":"10.1016\/j.jbc.2025.110341_bib44","doi-asserted-by":"crossref","first-page":"12488","DOI":"10.3390\/ijms241512488","article-title":"Brain mitochondrial bioenergetics in genetic neurodevelopmental disorders: focus on down, rett and fragile X syndromes","volume":"24","author":"Valenti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.110341_bib45","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00130.2021","article-title":"Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects","volume":"322","author":"Vandenberg","year":"2022","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.jbc.2025.110341_bib46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cell.2020.07.008","article-title":"ATP synthase c-subunit leak causes aberrant cellular metabolism in fragile X syndrome","volume":"182","author":"Licznerski","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110341_bib47","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1096\/fj.202000283RR","article-title":"Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome","volume":"34","author":"Griffiths","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2025.110341_bib48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2020.05.005","article-title":"Integrative analysis identifies key molecular signatures underlying neurodevelopmental deficits in fragile X syndrome","volume":"88","author":"Utami","year":"2020","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jbc.2025.110341_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acs.jproteome.7b00572","article-title":"BioPlex display: an interactive suite for large-scale AP-MS protein-protein interaction data","volume":"17","author":"Schweppe","year":"2018","journal-title":"J. Proteome. Res."},{"key":"10.1016\/j.jbc.2025.110341_bib50","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","article-title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome","volume":"184","author":"Huttlin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110341_bib51","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/cells12242807","article-title":"The identification of nuclear FMRP isoform Iso6 partners","volume":"12","author":"Ledoux","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110341_bib52","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.neuron.2023.09.014","article-title":"Species-specific FMRP regulation of RACK1 is critical for prenatal cortical development","volume":"111","author":"Shen","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2025.110341_bib53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bc0155061","article-title":"Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo","volume":"12","author":"Lee","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2025.110341_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389203033487289","article-title":"Modulation of cellular function by TAT mediated transduction of full length proteins","volume":"4","author":"Wadia","year":"2003","journal-title":"Curr. Protein. Pept. Sci."},{"key":"10.1016\/j.jbc.2025.110341_bib55","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/MCB.16.7.3825","article-title":"Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them","volume":"16","author":"Siomi","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2025.110341_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(00)80012-X","article-title":"FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association","volume":"1","author":"Feng","year":"1997","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jbc.2025.110341_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng0196-91","article-title":"The fragile X mental retardation protein is associated with ribosomes","volume":"12","author":"Khandjian","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.110341_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(94)90232-1","article-title":"Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome","volume":"77","author":"Siomi","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110341_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng0193-31","article-title":"A point mutation in the FMR-1 gene associated with fragile X mental retardation","volume":"3","author":"De Boulle","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.110341_bib60","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1523\/JNEUROSCI.17-05-01539.1997","article-title":"Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes","volume":"17","author":"Feng","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110341_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1074\/jbc.273.1.291","article-title":"p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase","volume":"273","author":"Kobayashi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110341_bib62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0959-437X(02)00300-3","article-title":"Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes","volume":"12","author":"Bardoni","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jbc.2025.110341_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.devcel.2023.03.002","article-title":"Deregulation of ER-mitochondria contact formation and mitochondrial calcium homeostasis mediated by VDAC in fragile X syndrome","volume":"58","author":"Geng","year":"2023","journal-title":"Dev. Cell."},{"key":"10.1016\/j.jbc.2025.110341_bib64","first-page":"1863","article-title":"STAU1 selectively regulates the expression of inflammatory and immune response genes and alternative splicing of the nerve growth factor receptor signaling pathway","volume":"44","author":"Zhong","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2025.110341_bib65","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1101\/gad.1566807","article-title":"Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function","volume":"21","author":"Isken","year":"2007","journal-title":"Genes. Dev."},{"key":"10.1016\/j.jbc.2025.110341_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13059-021-02530-9","article-title":"NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome","volume":"22","author":"Kurosaki","year":"2021","journal-title":"Genome. Biol."},{"key":"10.1016\/j.jbc.2025.110341_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1101\/gad.1717309","article-title":"SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs","volume":"23","author":"Gong","year":"2009","journal-title":"Genes. Dev."},{"key":"10.1016\/j.jbc.2025.110341_bib68","doi-asserted-by":"crossref","first-page":"15318","DOI":"10.1523\/JNEUROSCI.2162-12.2012","article-title":"Regulation of neuronal excitability by interaction of fragile X mental retardation protein with slack potassium channels","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110341_bib69","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/s41380-018-0240-0","article-title":"Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brain","volume":"25","author":"Yang","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jbc.2025.110341_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.neuroscience.2010.09.011","article-title":"Expression and distribution of Kv4 potassium channel subunits and potassium channel interacting proteins in subpopulations of interneurons in the basolateral amygdala","volume":"171","author":"Dabrowska","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2025.110341_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20082197","article-title":"A study of the ultrastructure of fragile-X-related proteins","volume":"419","author":"Sjeklo\u0107a","year":"2009","journal-title":"Biochem. J."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:38:51Z","timestamp":1761147531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582502191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S002192582502191X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110341","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactome of FMRP-N-tat therapeutic unveils key interactions for cellular function in Fragile X neurons","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110341"}}